A Novel Approach to Overcome Movement Artifact When Using a Laser Speckle Contrast Imaging System for Alternating Speeds of Blood Microcirculation
August 30th, 2017
9.7K views
This study introduces a novel technique for the measurement and analysis of alternating speeds of blood microcirculation in a single experiment using a laser speckle contrast imager.
Overview
This study introduces a novel technique for measuring and analyzing alternating speeds of blood microcirculation using a laser speckle contrast imager. The method addresses movement artifacts that can affect results, providing a reliable approach for researchers.
Key Study Components
Area of Science
- Neuroscience
- Microcirculation
- Imaging Techniques
Background
- Movement artifacts can significantly impact laser speckle contrast imaging (LSCI) results.
- Understanding blood microcirculation is crucial for clinical applications, such as post-surgical recovery.
- Previous studies indicated the need for improved methods to measure blood flow dynamics.
- LSCI is sensitive to movement, making accurate measurements challenging.
Purpose of Study
- To develop a method that minimizes movement artifacts in LSCI.
- To evaluate the effects of alternating blood flow speeds in a single experiment.
- To provide insights into microcirculation dynamics relevant to clinical settings.
Methods Used
- Setup of the moorFLPI LSCI system with specific configurations.
- Preparation of participants in a controlled environment to minimize external light.
- Application of an opaque patch to mask blood flow during measurements.
- Recording and analyzing blood flow data using defined regions of interest (ROIs).
Main Results
- The technique allows for accurate measurement of blood flow despite movement.
- Clear differentiation between slow and fast blood flow was achieved.
- Results indicated a reliable method for assessing microcirculation dynamics.
- Potential applications include monitoring devices for wound healing.
Conclusions
- This method enhances the reliability of blood microcirculation studies.
- It opens avenues for further research into microcirculatory flow enhancement devices.
- Proper configuration is essential for obtaining accurate measurements.
Frequently Asked Questions
What is the main advantage of this technique?
The technique overcomes movement artifacts that typically affect LSCI, allowing for more accurate measurements of blood microcirculation.
How does the method ensure accurate measurements?
By using an opaque patch to mask blood flow and configuring the imaging setup to minimize external light and movement.
What are the clinical implications of this study?
The findings could help in understanding the relationship between microcirculation and recovery in post-surgical patients.
How long does the procedure take?
Once mastered, the technique can be performed in approximately 20 minutes.
What is the significance of using regions of interest (ROIs)?
ROIs allow for focused analysis of blood flow in specific areas, enhancing measurement accuracy.
Can this method be applied to other experiments?
Yes, it can be adapted for studies involving monitoring devices that aim to improve wound healing.
Executive Industry Relevance
Laser speckle contrast imaging (LSCI) is a non-invasive tool for assessing microcirculatory blood flow, but its high sensitivity to movement artifacts limits utility in dynamic physiological studies. This protocol introduces an adhesive opaque patch (AOP) method to subtract background signal and enable reliable measurement of alternating slow and fast blood flux in a single experiment. By expressing flux as percentage change from a baseline rest stage, the approach supports mechanistic de-risking in preclinical models of vascular response and wound healing.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses involving blood flow modulation, such as vasodilatory or vasoconstrictive compound effects.
- Operational Value: Provides a quantitative, reproducible readout for pathway clarification in angiogenesis or inflammation models.
- Predictive Value: Supports target confidence by distinguishing compound-induced flow changes from motion-induced noise.
Screening & Assay Development
- Assay Readiness: Prepares validated biological systems for downstream compound screening by establishing stable flux baselines.
- Quantitative Output: Delivers normalized flux measurements (percentage change from baseline) suitable for dose-response modeling.
- Scalability: Supports high-contrast imaging across skin areas up to 15 cm x 20 cm, enabling multi-parameter screening.
Translational & Preclinical Research
- Disease-Relevant System: Applicable to models of post-surgical edema, wound healing, and ischemic recovery where microcirculatory dynamics are key.
- Translational Continuity: Bridges discovery-phase mechanism validation with preclinical efficacy assessment via consistent flux metrics.
- Risk-Adjusted Advancement: Enables go/no-go decisions based on hemodynamic response profiles rather than artifact-confounded data.
Pipeline & Workflow Integration
The method fits within the discovery-to-preclinical continuum, supporting early target validation through hemodynamic phenotyping and informing lead identification via flow-based biomarker alignment.
- Discovery Biology: Supports hypothesis testing of compounds affecting vascular tone or endothelial function through direct flux measurement.
- Screening: Enables assay standardization by minimizing movement-related variability, improving Z-factor and hit selection confidence.
- Analytics: Generates time-resolved flux data and baseline-normalized outputs that facilitate inter-group comparison and statistical modeling.
- Translational Research: Connects to preclinical wound healing or reperfusion studies where alternating flow speeds reflect physiological challenge responses.
- Enterprise Reuse: Represents a reusable imaging capability across dermatology, cardiovascular, and metabolic disease programs requiring microcirculatory assessment.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence by isolating true biological signal from motion artifact in dynamic flow studies.
- Operational Value: Enhances reproducibility and standardization across users and sites through defined ROI placement and exposure settings.
- Strategic Value: Reduces late-stage biological risk by improving early detection of ineffective or pro-ischemic candidates.
- Portfolio Impact: Enables risk-adjusted prioritization of vascular-modulating compounds based on reliable microcirculatory flux profiles.
Implementation Considerations
- Requires expertise in optical imaging and region-of-interest selection to avoid signal contamination.
- Dependent on stable instrumentation setup, including moorFLPI LSCI, FireWire interface, and controlled ambient lighting.
- Necessitates cross-team standardization of ROI placement, patch application, and baseline protocol adherence.
- Adaptation considerations include skin pigmentation, hair coverage, and curvature affecting patch adhesion and signal uniformity.
- Practical limitation: Method assumes opaque patch fully masks underlying blood flow; validation needed for highly vascular or pigmented tissues.
Biopharma FAQs
Why does subtracting the opaque patch signal improve flux measurement accuracy?
Subtracting the signal from the adhesive opaque patch removes background noise and movement artifact, isolating the true blood flow signal from the skin. This enables reliable detection of both slow and fast microcirculatory flux changes. The approach is essential when the subject cannot remain perfectly still during measurement.
How does isolating the independent variable (e.g., stimulation mode) support discovery pipeline decisions?
By controlling for movement artifact, the method ensures that observed flux changes are attributable to the independent variable, such as neuromuscular stimulation or compression therapy. This increases confidence in target mechanism validation. It supports go/no-go decisions by linking hemodynamic response directly to compound or device action.
What do quantitative dependent variable measurements (percentage flux change from baseline) enable in preclinical studies?
Expressing flux as percentage change from a rest-stage baseline allows for normalized comparison across subjects, conditions, and time points. This supports dose-response modeling and inter-group statistical analysis. It enables detection of subtle but biologically relevant flow modulations that might be missed in raw signal analysis.
Why are replication requirements important for cross-functional collaboration in drug discovery?
Replication ensures that flux measurements are consistent across operators, sessions, and laboratories, which is critical for multi-site preclinical studies. Standardized ROI placement, exposure time, and baseline recording reduce variability. This consistency enables reliable data sharing between discovery, toxicology, and translational teams.
What statistical analysis capabilities are required before implementing this method in a discovery workflow?
Teams must be able to perform baseline-normalized flux analysis, calculate mean flux within defined ROIs, and assess statistical significance across conditions (e.g., rest vs. stimulation). The method supports parametric testing when data is normally distributed and sufficient replicates are available. These capabilities are essential for interpreting compound effects on microcirculation with predictive confidence.
